Cross-protective efficacy of two human papillomavirus vaccines: a systematic review and meta-analysis
Background The extent of cross-protection is a key element in the choice of human
papillomavirus (HPV) vaccine to use in vaccination programmes. We compared the cross …
papillomavirus (HPV) vaccine to use in vaccination programmes. We compared the cross …
Cross-protective efficacy of two human papillomavirus vaccines: A systematic review and meta-analysis
T Malagón, M Drolet, MC Boily… - The Lancet …, 2012 - researchportal.ukhsa.gov.uk
Background: The extent of cross-protection is a key element in the choice of human
papillomavirus (HPV) vaccine to use in vaccination programmes. We compared the cross …
papillomavirus (HPV) vaccine to use in vaccination programmes. We compared the cross …
Cross-protective efficacy of two human papillomavirus vaccines: a systematic review and meta-analysis.
T Malagón, M Drolet, MC Boily, EL Franco… - The Lancet. Infectious …, 2012 - europepmc.org
Background The extent of cross-protection is a key element in the choice of human
papillomavirus (HPV) vaccine to use in vaccination programmes. We compared the cross …
papillomavirus (HPV) vaccine to use in vaccination programmes. We compared the cross …
Cross-protective efficacy of two human papillomavirus vaccines: a systematic review and meta-analysis
T Malagón, M Drolet, MC Boily, EL Franco, M Jit… - The Lancet Infectious …, 2012 - infona.pl
The extent of cross-protection is a key element in the choice of human papillomavirus (HPV)
vaccine to use in vaccination programmes. We compared the cross-protective efficacy of the …
vaccine to use in vaccination programmes. We compared the cross-protective efficacy of the …
Cross-protective efficacy of two human papillomavirus vaccines: a systematic review and meta-analysis
T Malagón, M Drolet, MC Boily… - The Lancet …, 2012 - pubmed.ncbi.nlm.nih.gov
Background The extent of cross-protection is a key element in the choice of human
papillomavirus (HPV) vaccine to use in vaccination programmes. We compared the cross …
papillomavirus (HPV) vaccine to use in vaccination programmes. We compared the cross …
[PDF][PDF] Cross-protective efficacy of two human papillomavirus vaccines: a systematic review and meta-analysis
T Malagón, M Drolet, MC Boily, EL Franco, M Jit… - Lancet Infect …, 2012 - nitag-resource.org
Background The extent of cross-protection is a key element in the choice of human
papillomavirus (HPV) vaccine to use in vaccination programmes. We compared the cross …
papillomavirus (HPV) vaccine to use in vaccination programmes. We compared the cross …
Cross-protective efficacy of two human papillomavirus vaccines: a systematic review and meta-analysis.
T Malagón, M Drolet, MC Boily… - The Lancet …, 2012 - researchonline.lshtm.ac.uk
BACKGROUND: The extent of cross-protection is a key element in the choice of human
papillomavirus (HPV) vaccine to use in vaccination programmes. We compared the cross …
papillomavirus (HPV) vaccine to use in vaccination programmes. We compared the cross …
Cross-protective efficacy of two human papillomavirus vaccines: a systematic review and meta-analysis
T Malagón, M Drolet, MC Boily, EL Franco… - The Lancet Infectious …, 2012 - thelancet.com
Background The extent of cross-protection is a key element in the choice of human
papillomavirus (HPV) vaccine to use in vaccination programmes. We compared the cross …
papillomavirus (HPV) vaccine to use in vaccination programmes. We compared the cross …
[引用][C] Cross-protective efficacy of two human papillomavirus vaccines: a systematic review and meta-analysis
T Malagón, M Drolet, MC Boily, EL Franco… - The Lancet Infectious …, 2012 - cir.nii.ac.jp
Cross-protective efficacy of two human papillomavirus vaccines: a systematic review and
meta-analysis | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ …
meta-analysis | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ …